Bagmane Prime Office REIT IPO Final Day: GMP ₹4 (₹-1)

Well folks, here we are. It’s the final day, the closing bell for the Bagmane Prime Office REIT IPO on the NSE’s mainboard. As we wrap up the subscription period from May 5th to May 7th, 2026, it’s time to take a good, hard look at where we stand. The issue price is set at ₹95, and while the Grey Market Premium (GMP) has seen a slight dip, we need to see how the actual subscription numbers have panned out on this crucial last day. Let’s dive in.

Subscription Status

The subscription numbers are what we’ve all been waiting for, especially on Day 3. However, looking at the data for Bagmane Prime Office REIT, we see a concerning trend: Retail 0x, NII 0x, QIB 0x, and a Total subscription of 0x. This is quite unusual, especially for a mainboard IPO. Typically, by the closing day, we’d expect to see some level of interest across all categories, even if it’s modest. A 0x subscription across the board, particularly for Retail and NII (Non-Institutional Investors), suggests a significant lack of investor engagement. Qualified Institutional Buyers (QIBs) also showing zero interest is a major red flag. This could indicate that institutional investors, who often lead the charge and provide validation, haven’t found the offering compelling enough. For retail investors, this lack of interest from larger players might be a signal to exercise caution. It’s hard to gauge sentiment when the numbers are this flat, and it certainly doesn’t paint a picture of strong demand.

GMP Update

Now, let’s talk about the Grey Market Premium (GMP). The current GMP is sitting at ₹4. Yesterday, it was ₹5. This represents a decrease of ₹1. While a ₹4 GMP isn’t a complete washout, the downward trend is something to keep an eye on. A declining GMP, especially on the closing day, can sometimes reflect weakening sentiment or a reassessment of the IPO’s potential by the grey market. The expected listing price, based on this GMP, is around ₹99 (Issue Price ₹95 + GMP ₹4). This suggests a modest potential gain if the GMP holds steady until listing. However, the fact that it has decreased from yesterday is a point of caution. It’s not a dramatic fall, but it’s a movement in the wrong direction, and we’ll need to see if it stabilizes or continues to slide.

Should You Apply?

So, the big question: should you apply for the Bagmane Prime Office REIT IPO? The subscription numbers are, to put it mildly, perplexing and concerning. A 0x subscription across all categories on the closing day is highly unusual and suggests a significant lack of demand. This is compounded by a declining GMP, which, while still positive, is showing a slight weakening of market sentiment. The expected listing price of ₹99 offers a small potential upside, but it’s built on a foundation of very weak demand indicators.

SEBI advisors often recommend looking at strong subscription levels as a primary indicator of investor interest and potential listing gains. In this case, the subscription data is a clear deterrent. That said, the GMP, though down, is still indicating a positive listing. The bottom line is that this IPO presents a very mixed and, frankly, unusual picture. Given the extreme lack of subscription data, it might be prudent for most retail investors to wait and see how the listing plays out. If you’re considering applying, do so with extreme caution and only if you have a very high-risk appetite.

For more detailed information and ongoing updates, you can always check out the full IPO details here: View Full Bagmane Prime Office REIT IPO Details.